Skin immunization for effective treatment of multifocal melanoma refractory to PD1 blockade and Braf inhibitors

BACKGROUND: Despite the remarkable benefits associated with the interventional treatment of melanomas (and other solid cancers) with immune checkpoint and Braf inhibitors (Brafi), most patients ultimately progress on therapy. The presence of multifocal/disseminated disease in patients increases thei...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Xingxing, Falo III, Louis D, Chen, Guo, Zhang, Jiying, Carey, Cara D, Storkus, Walter J, Falo Jr, Louis D, You, Zhaoyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789470/
https://www.ncbi.nlm.nih.gov/pubmed/33408093
http://dx.doi.org/10.1136/jitc-2020-001179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789470/
https://www.ncbi.nlm.nih.gov/pubmed/33408093
http://dx.doi.org/10.1136/jitc-2020-001179

Ejemplares similares